Zobrazeno 1 - 10
of 23
pro vyhledávání: '"María Inés Sosa-Liprandi"'
Autor:
Álvaro Sosa Liprandi, María Inés Sosa Liprandi, Ezequiel José Zaidel, Gabriel M. Aisenberg, Adrián Baranchuk, Eduardo Costa Duarte Barbosa, Gabriela Borrayo Sánchez, Bryce Alexander, Fernando Tomás Lanas Zanetti, Ricardo López Santi, Ana Girleza Múnera-Echeverri, Pablo Perel, Daniel Piskorz, Carlos Enrique Ruiz-Mori, Jorge Saucedo, Osiris Valdez, José Ramón González Juanatey, Daniel José Piñeiro, Fausto J. Pinto, Fernando Stuardo Wyss Quintana
Publikováno v:
Global Heart, Vol 16, Iss 1 (2021)
Background: Cardiovascular mortality is decreasing but remains the leading cause of death world-wide. Respiratory infections such as influenza significantly contribute to morbidity and mortality in patients with cardiovascular disease. Despite of pro
Externí odkaz:
https://doaj.org/article/d5397ea8250e43419c8842658043a383
Publikováno v:
European Heart Journal Supplements. 25:A31-A35
The purpose of this review is to update the recent information regarding the role of influenza vaccination (IV) as a strategy to reduce cardiovascular (CV) events. During the last 2 years, new meta-analysis, guidelines, and two randomized controlled
Impact of a Telemedicine Program After a Heart Failure Hospitalization on 12 Months Follow-Up Events
Autor:
María Inés Sosa Liprandi, Melisa Elfman, Ezequiel José Zaidel, Matías Viniegra, Álvaro Sosa Liprandi
Publikováno v:
Current Problems in Cardiology. 48:101624
Publikováno v:
Cardiovascular and Metabolic Science. 33:s439-441
Publikováno v:
ABC: Heart Failure & Cardiomyopathy. 1:103-111
Autor:
Sebastián, García-Zamora, María Inés, Sosa Liprandi, José M, Picco, María Gabriela, Matta, Ricardo, Villarreal, Laura, Pulido, Daniel, Stecher, Claudio, Morós, Miriam, Rozenek Pisterman, Valeria, Barone, Marisa, Pacheco Otero, Pablo, Merlo, Sebastián, Ghibaudo, Ludmila, Morcos, Mariel, Calabró, Javier, Mariani, Carlos M, Luna, Francisco, Nacinovich
Publikováno v:
Medicina (Buenos Aires), Vol 80, Iss 5, Pp 541-553 (2020)
Cardiovascular diseases are the leading cause of death in most regions of the world, usually followed by infectious diseases. For decades, infections in general, and particularly those involving the respiratory system, have been known to be associate
Autor:
Ezequiel José Zaidel, Erna Florencia Segovia, Sebastian Nuñez, Luis C Palomino Romero, Ernesto Caliva, José Fabián Arcos Alcívar, Joaquín Perea, Matías Ariel Oliva, Lara Gheco, Luis Guillermo García Chamorro, Melisa Elfman, Horacio Germán Cestari, Ricardo Alfredo Villarreal, María Inés Sosa Liprandi, Álvaro Sosa Liprandi
Publikováno v:
Interamerican Journal of Health Sciences.
This is the first report of mid-term evolution of patients with COVID-19 and Chagas Disease (CD). General characteristics, in-hospital evolution, and mid-term follow up of 12 consecutive patients at a single centre is described. A call for action is
Autor:
María Inés Sosa Liprandi, Pablo Perel, Ana Girleza Múnera-Echeverri, Eduardo Costa Duarte Barbosa, Adrian Baranchuk, Daniel Piskorz, Gabriel M Aisenberg, Alvaro Sosa Liprandi, José Ramón González Juanatey, Fausto J. Pinto, Daniel J. Piñeiro, Ricardo Lopez Santi, Carlos Enrique Ruiz-Mori, Gabriela Borrayo Sánchez, Fernando S Wyss Quintana, Fernando Lanas Zanetti, Jorge Saucedo, Osiris Valdez, Ezequiel J. Zaidel, Bryce Alexander
Publikováno v:
Global Heart
Global Heart, Vol 16, Iss 1 (2021)
Global Heart; Vol 16, No 1 (2021); 55
Global Heart, Vol 16, Iss 1 (2021)
Global Heart; Vol 16, No 1 (2021); 55
Background\ud Cardiovascular mortality is decreasing but remains the leading cause of death world-wide. Respiratory infections such as influenza significantly contribute to morbidity and mortality in patients with cardiovascular disease. Despite of p
Autor:
Andrew C.T. Ha, Ana C. Alba, Alejandro Ochoa, María Inés Sosa Liprandi, Meyer S. Balter, Alvaro Sosa Liprandi, Shyla Gupta, Lakshmi Kugathasan
Publikováno v:
Current problems in cardiology. 46(10)
Cardiac sarcoidosis (CS) with clinical manifestation occurs in about 5-8% of patients with sarcoidosis. CS may be clinically suspected by the presence of ventricular arrhythmia, conduction abnormalities, and heart failure (HF). However, 20%-25% of pa
Autor:
Alvaro Sosa Liprandi, Fernando Wyss, Clara Saldarriaga, Oswaldo Andrés Ballesteros, Adrian Baranchuk, María Inés Sosa Liprandi, Cristhian Emmanuel Scatularo, Edith Liliana Posada Martínez
Publikováno v:
Current problems in cardiology. 46(4)
Endomyocardiofibrosis was described first time in Uganda as an infrequent restrictive cardiomyopathy with a poor prognosis, characterized by fibrosis of the ventricular subendocardium and severe restrictive physiology leading to difficult therapeutic